Whole-genome sequencing of nine esophageal adenocarcinoma cell lines
Research output: Contribution to journal › Article › peer-review
Standard
Whole-genome sequencing of nine esophageal adenocarcinoma cell lines. / Contino, Gianmarco; Eldridge, Matthew D.; Secrier, Maria; Bower, Lawrence; Elliott, Rachael Fels; Weaver, Jamie; Lynch, Andy G.; Edwards, Paul A.W.; Fitzgerald, Rebecca C.
In: F1000Research, Vol. 5, 1336, 10.06.2016.Research output: Contribution to journal › Article › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Whole-genome sequencing of nine esophageal adenocarcinoma cell lines
AU - Contino, Gianmarco
AU - Eldridge, Matthew D.
AU - Secrier, Maria
AU - Bower, Lawrence
AU - Elliott, Rachael Fels
AU - Weaver, Jamie
AU - Lynch, Andy G.
AU - Edwards, Paul A.W.
AU - Fitzgerald, Rebecca C.
N1 - Open Peer Review, this version: version 1; peer review: 3 approved.
PY - 2016/6/10
Y1 - 2016/6/10
N2 - Esophageal adenocarcinoma (EAC) is highly mutated and molecularly heterogeneous. The number of cell lines available for study is limited and their genome has been only partially characterized. The availability of an accurate annotation of their mutational landscape is crucial for accurate experimental design and correct interpretation of genotype-phenotype findings. We performed high coverage, paired end whole genome sequencing on eight EAC cell lines-ESO26, ESO51, FLO-1, JH-EsoAd1, OACM5.1 C, OACP4 C, OE33, SK-GT-4-all verified against original patient material, and one esophageal high grade dysplasia cell line, CP-D. We have made available the aligned sequence data and report single nucleotide variants (SNVs), small insertions and deletions (indels), and copy number alterations, identified by comparison with the human reference genome and known single nucleotide polymorphisms (SNPs). We compare these putative mutations to mutations found in primary tissue EAC samples, to inform the use of these cell lines as a model of EAC.
AB - Esophageal adenocarcinoma (EAC) is highly mutated and molecularly heterogeneous. The number of cell lines available for study is limited and their genome has been only partially characterized. The availability of an accurate annotation of their mutational landscape is crucial for accurate experimental design and correct interpretation of genotype-phenotype findings. We performed high coverage, paired end whole genome sequencing on eight EAC cell lines-ESO26, ESO51, FLO-1, JH-EsoAd1, OACM5.1 C, OACP4 C, OE33, SK-GT-4-all verified against original patient material, and one esophageal high grade dysplasia cell line, CP-D. We have made available the aligned sequence data and report single nucleotide variants (SNVs), small insertions and deletions (indels), and copy number alterations, identified by comparison with the human reference genome and known single nucleotide polymorphisms (SNPs). We compare these putative mutations to mutations found in primary tissue EAC samples, to inform the use of these cell lines as a model of EAC.
KW - Esophageal adenocarcinoma
KW - whole genome sequencing
KW - cell line
KW - high-grade dysplasia
KW - cancer genome
KW - copy number alteration
KW - single nucleotide variant
UR - http://www.scopus.com/inward/record.url?scp=85010840102&partnerID=8YFLogxK
UR - https://www.repository.cam.ac.uk/handle/1810/288830
U2 - 10.12688/F1000RESEARCH.7033.1
DO - 10.12688/F1000RESEARCH.7033.1
M3 - Article
AN - SCOPUS:85010840102
VL - 5
JO - F1000Research
JF - F1000Research
SN - 2046-1402
M1 - 1336
ER -